Axcella Therapeutics (AXLA) Tops Q1 EPS by 7c

Axcella Therapeutics (NASDAQ: AXLA) reported Q1 EPS of ($0.05), $0.07 better than the analyst estimate of ($0.12).

For earnings history and earnings-related data on Axcella Therapeutics (AXLA) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance
• Motorsport Games Inc. (MSGM) Tops Q2 EPS by 33c